Skip to Content

Pfizer CRZ 250 (Xalkori 250 mg)

Generic Name: crizotinib

Pill with imprint Pfizer CRZ 250 is Pink, Capsule-shape and has been identified as Xalkori 250 mg. It is supplied by Pfizer Inc..

Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer CRZ 250

Xalkori

Generic Name
crizotinib
Imprint
Pfizer CRZ 250
Strength
250 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-8140

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.